Ordering
Available Variants10 mg
CHA.35445-10mg
Price
€143.20
Available – Dispatch in 14 days
50 mg
CHA.35445-50mg
Price
€574.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.35445-10mg | €143.20 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.35445-50mg | €574.40 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C15H20F3N3O3S |
|---|---|
| CAS Number | 141283-87-6 |
| Molecular Weight | 379.40 |
| UNSPSC Code | 51111800 |
| NACRES | NA.77 |
| MDL number | MFCD00908408 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Fuzapladib, also known by its CAS number 141283-87-6, is a potent and selective inhibitor of the enzyme diacylglycerol lipase alpha. This enzyme plays a crucial role in the biosynthesis of 2-arachidonoylglycerol, a key endocannabinoid involved in various physiological processes. By inhibiting diacylglycerol lipase alpha, Fuzapladib has been shown to increase the levels of 2-arachidonoylglycerol in the brain, which may have therapeutic implications for the treatment of neurological disorders. Research has demonstrated that Fuzapladib exhibits high affinity and selectivity for its target enzyme, with minimal off-target effects. As a result, Fuzapladib has been investigated as a potential therapeutic agent for the treatment of various conditions, including pain, inflammation, and neurological diseases, highlighting its potential as a valuable tool for further scientific study and potential clinical applications. Further research is needed to fully explore its therapeutic potential.
